Immunoreactive trypsin and a comparison of two ΔF508 mutation analyses in newborn screening for cystic fibrosis: An anonymous pilot study in Denmark
- 31 March 1993
- Vol. 2 (1) , 1-11
- https://doi.org/10.1016/0925-6164(93)90012-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Detection of mutation delta F508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry.Genome Research, 1992
- Cystic fibrosis: Beyond the gene to therapyThe Journal of Pediatrics, 1992
- Couple screening for cystic fibrosisThe Lancet, 1991
- Efficacy of Statewide Neonatal Screening for Cystic Fibrosis by Assay of Trypsinogen ConcentrationsNew England Journal of Medicine, 1991
- Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.BMJ, 1991
- Frequency of the ΔF508 mutation on cystic fibrosis chromosomes in DenmarkHuman Genetics, 1990
- Identification of the Cystic Fibrosis Gene: Chromosome Walking and JumpingScience, 1989
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989
- Cystic fibrosis screening by dried blood spot trypsin assay: Results in 75,000 newborn infantsThe Journal of Pediatrics, 1983
- DRIED-BLOOD SPOT SCREENING FOR CYSTIC FIBROSIS IN THE NEWBORNThe Lancet, 1979